Roche
Roche Pharmaceuticals in the U.S.
Home About Us R&D Products Programs & Services Careers Newsroom
Search | Site Map | Contact
Search Site Map Contact
Roche Pharmaceuticals in the U.S. Virtual Newsroom

2008 Press Releases
 
Search the releases for: Press Release Archive:
2008  2007  2006 
May 2008
 
05-09-2008 ROCHE’S VIDAL HONORED AS 2008 HBA RISING STAR
 
05-02-2008 ROCHE RESEARCH DIRECTOR GRACE JU HAILED AS NJABR “OUTSTANDING WOMAN OF SCIENCE”
 
05-02-2008 TWO ROCHE WOMEN HONORED AS 2008 TRIBUTE TO WOMEN AND INDUSTRY AWARDEES
 
April 2008
 
04-26-2008 ROCHE’S INVESTIGATIONAL HEPATITIS C POLYMERASE INHIBITOR, R1626, DEMONSTRATED SIGNIFICANT END-OF-TREATMENT RESPONSE IN PHASE IIA STUDY
 
04-26-2008 THREE STUDIES PRESENTED AT 43RD EASL SHOWED HIGHER SVR FOR PEGASYS® (PEGINTERFERON ALFA-2A) PLUS RIBAVIRIN THAN PEGINTERFERON ALFA-2B PLUS RIBAVIRIN IN TREATING HEPATITIS C
 
04-18-2008 NOVEL XELODA® DOSING SCHEDULE MAY OFFER WELL-TOLERATED ALTERNATIVE FOR TREATMENT OF ADVANCED BREAST CANCER
 
04-15-2008 ROCHE GAINS ACCESS TO IMPORTANT ONCOLOGY TARGET WITH POTENTIAL FOR TREATING MAJOR CANCERS SUCH AS BREAST AND LUNG; FIRST DRUG CANDIDATE IN PHASE I CLINICAL TESTING
 
March 2008
 
03-20-2008 INTERNATIONAL ACTEMRA RHEUMATOID ARTHRITIS STUDY HIGHLIGHTED IN THE LANCET
 
 
 
 


"THIS SITE INTENDED FOR U.S. AUDIENCES ONLY"
Copyright © 2002- Hoffmann-La Roche Inc. All rights reserved. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and PRIVACY Statement.